Yayın:
Bevacuzimab May Be Less Effective in Obese Metastatic Colorectal Cancer Patients

Sadeleştirilmiş öğe sayfası
dc.contributor.authorTurhal, N. S.
dc.contributor.authorLevent Korkmaz
dc.contributor.authorHasan Şenol Çoşkun
dc.contributor.authorFaysal Dane
dc.contributor.authorBülent Karabulut
dc.contributor.authorMustafa Karaağaç
dc.contributor.authorDevrim Çabuk
dc.contributor.authorSenem Karabulut
dc.contributor.authorNuri Faruk Aykan
dc.contributor.authorHüseyin Doruk
dc.contributor.authorNilüfer Avcı
dc.contributor.authorN. S. Turhal
dc.contributor.orcid0000-0003-2335-3354
dc.contributor.orcid0000-0001-6931-6896
dc.contributor.orcid0000-0003-2969-7561
dc.contributor.orcid0000-0001-6584-902X
dc.contributor.orcid0000-0002-1949-8334
dc.contributor.orcid0000-0003-4533-0620
dc.contributor.orcid0000-0002-7871-6311
dc.contributor.orcid0000-0003-4740-9973
dc.contributor.orcid0000-0002-5472-3218
dc.contributor.orcid0000-0003-3534-2628
dc.contributor.orcid0000-0002-1013-5676
dc.date.accessioned2025-11-13T10:11:05Z
dc.date.issued2018-01-04
dc.identifier.doihttps://doi.org/10.1007/s12029-017-0047-2
dc.identifier.endpage220
dc.identifier.issn1941-6628
dc.identifier.issue2
dc.identifier.openalexW2782224966
dc.identifier.startpage214
dc.identifier.urihttps://hdl.handle.net/11421/3382
dc.identifier.urihttps://doi.org/10.1007/s12029-017-0047-2
dc.identifier.volume50
dc.language.isoen
dc.relation.ispartofJournal of Gastrointestinal Cancer
dc.rightsrestrictedAccess
dc.subjectMedicine
dc.subjectBevacizumab
dc.subjectInternal medicine
dc.subjectColorectal cancer
dc.subjectChemotherapy
dc.subjectOncology
dc.subjectKRAS
dc.subjectObesity
dc.subjectProgression-free survival
dc.subjectCancer
dc.subjectGastroenterology
dc.subject.sdg3
dc.titleBevacuzimab May Be Less Effective in Obese Metastatic Colorectal Cancer Patients
dc.typeArticle
dspace.entity.typePublication
local.authorid.openalexA5064011743

Dosyalar

Koleksiyonlar

Publications